Viewing nowFosiel Tablet 10mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 202201075 · Approved 2022.03.15 · Insurance code 649702930
Improvement of blood glucose control in type 2 diabetes, chronic heart failure, and prevention of worsening of chronic kidney disease
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can help reduce the occurrence of cardiovascular events in patients, particularly those with cardiovascular disease or risk factors, in addition to controlling blood sugar. For patients with chronic heart failure, it is administered alongside other standard therapies to reduce the risks of death, hospitalization, and emergency visits due to heart failure. It is also effective in chronic kidney disease patients for decreasing the risk of declining renal function and cardiovascular-related mortality. Thus, this medication is widely used in the treatment of diabetes, heart failure, and chronic kidney disease, contributing to patients' health improvement.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug therapy, when administered in combination with metformin, the recommended initial dose of this drug is 5 mg once daily or 10 mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. Individuals who are allergic to the main ingredient or additives, patients with type 1 diabetes or diabetic ketoacidosis, individuals with genetic issues such as lactose intolerance, and those undergoing dialysis should not take this medication. Patients with dehydration or poor kidney function should use this medication cautiously. This medication may cause side effects related to blood pressure lowering or changes in kidney function; therefore, fluid status and kidney function should be carefully monitored before and during administration. The most common side effect of this medication is genital infections. Other reported side effects include hypoglycemia, dehydration, dizziness, thirst, constipation, back pain, dysuria, polyuria, nocturia, etc. Severe metabolic disorders such as diabetic ketoacidosis may rarely occur, so if related symptoms appear, immediate consultation with healthcare professionals is necessary. The risk of urinary tract infections and pyelonephritis may increase, and attention should be given to elevated creatinine levels associated with kidney function changes. A rare but severe infection called necrotizing fasciitis may occur; if there is pain, redness, or swelling in the perineum, immediate treatment is required. Elderly patients or those taking diuretics are at higher risk of dehydration and hypotension and should be monitored closely. It is recommended that women who are pregnant or breastfeeding do not use this medication, and if pregnancy is confirmed, therapy should be discontinued. This medication may increase the risk of hypoglycemia when used with other hypoglycemic agents such as insulin or sulfonylureas; therefore, dose adjustments of these medications may be necessary. There is no specific antidote for overdose; treatment should be symptomatic. Finally, this medication is not recommended for use in children as safety and efficacy have not been established.
Vulvovaginitis, balanitis and related genital infections, urinary tract infection, fungal infection, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased creatinine clearance in the early treatment phase, dyslipidemia, increased serum creatinine in the early treatment phase, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, chronic gastritis, diverticulitis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyp, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, periodontal disease, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, increased serum lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, fatigue, chest discomfort, peripheral edema, systemic edema, hunger, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.
Yellow, biconvex rhomboid film-coated tablet
28 tablets/PTP [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
GL Pharma Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.